Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Clinical trial NCT01459796 · TERMINATED
Trial details
- NCT number
- NCT01459796
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-06-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.